Baptist Health Center for Clinical Research is conducting a late-stage, Phase 3 study on a potential COVID-19 vaccine, and is recruiting volunteers to participate.
Baptist Health Center for Clinical Research’s involvement is part of its Arkansas COVID Vaccine Initiative. Baptist Health is the only site in the state offering this study, which seeks to evaluate the safety and effectiveness of this vaccine candidate.
Baptist Health Center for Clinical Research’s study coincides with a broader nationwide effort, Operation Warp Speed, which was announced in May as a public-private partnership to facilitate, at an unprecedented pace, the development, manufacturing, and distribution of COVID-19 measures including vaccines, diagnostics, and treatments. The goal is to develop a safe, effective vaccine for COVID-19 by January of 2021.
“Everyone is at risk of infection, but at particular risk are people working outside of the home in healthcare, emergency response, factory settings with close quarters, hotels, restaurants, grocery stores, and retail as well as city employees and any other occupation that involves contact with the public. In addition, all people over 65 are susceptible to developing severe complications from the disease,” says Richard G. Pellegrino, MD, PhD, CEO and president of the Baptist Health Center for Clinical Research.
“No vaccine or specific antiviral treatment is currently available to fight COVID-19, and the best prevention method currently is to avoid exposure. There is an urgent public health need for rapid development of a vaccine to prevent the spread of the disease.”
If you are interested and would like more information, visit arkansascovidvaccine.com and fill out the contact form. Filling out the form does not commit you to the study, but you will be contacted to provide more information and to answer additional questions.
Study-related care is available to participants at no cost and health insurance is not required nor needed. Participants will be compensated for time and travel if they qualify and enroll in the COVID-19 vaccine study.